Shareholder alert: labaton sucharow investigates claims on behalf of investors of athenex, inc. (nasdaq: atnx)

New york--(business wire)--labaton sucharow, a nationally ranked and award-winning shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against athenex, inc. (nasdaq: atnx). shares are down over 50% after the company reported q4 results and received a complete response letter from the fda regarding its new drug application for oral paclitaxel plus encequidar for the treatment of metastatic breast cancer. the fda expressed the following: c
ATNX Ratings Summary
ATNX Quant Ranking